Possible New Target for Sickle Cell Disease and Beta Thalassemia Treatment identified by Harvard Medical School Researchers

Researchers identify additional gene controlling production of fetal hemoglobin Harvard Medical School researchers at Boston Children’s Hospital and Dana-Farber Cancer Institute have identified a new pathway that regulates the production of fetal hemoglobin, a form of hemoglobin that normally gets replaced soon after birth by adult hemoglobin. Two FDA-approved gene therapies reactivate the production of

Read More


Retatrutide, new  Triple Hormone Receptor Agonist, Improves Weight Loss up to 30%, Knee Osteoarthritis Pain, Sleep Apnea Versus Placebo

Retatrutide treatment results in substantial weight loss among patients with obesity, as well as reduced pain in patients with knee osteoarthritis and reduced apnea-hypopnea events in patients with obstructive sleep apnea, according to the TRIUMPH-1 study.1 Earlier phase 2 trials including patients with obesity have indicated that once-weekly subcutaneous retatrutide resulted in substantial weight reductions

Read More


New Study: Blood Test Shows Promise for Detecting Pancreatic Cancer at Its Earliest Stages

PANXEON, which combines multiple biomarkers, also identified a precancerous condition of the pancreas, potentially opening a path to intervention before invasive cancer develops One reason pancreatic cancer remains so deadly is because it’s usually discovered late, after it has spread. Now, a major new study shows that a blood test developed by researchers led by

Read More


Implantable device may help restore function after spinal cord injury

Ultra thin, flexible interface locates alternative signal pathways to bypass affected area Researchers from Houston Methodist and the University of Cambridge have developed a flexible device that wraps around the spinal cord and can simultaneously interpret multiple signals related to movement, sensation and internal body functions. The research demonstrates that a single device may be

Read More


Risk thresholds for kidney disease confirmed by more precise measurements

The kidney function thresholds currently used to diagnose chronic kidney disease reflect an actual increase in the risk of serious disease, according to a study from Karolinska Institutet and Leiden University Medical Center published in the journal JAMA. The researchers also show that risk assessment becomes more accurate when two common blood tests, creatinine and

Read More


Gene Expression ‘Clocks’ Reveal Shared Molecular Signatures of Aging and Mortality Across Mammals

Mass General Brigham researchers identify conserved gene expression signatures linked to biological aging and risk of disease and mortality, offering a new framework for quantifying aging and evaluating interventions that modulate healthspan and lifespan A team led by investigators at Mass General Brigham has discovered that different tissues in humans and other mammals share common gene expression

Read More


Oral Medication Proves Effective for Low Platelets Due to Chemotherapy

Summary The oral medication avatrombopag proved highly effective against chemotherapy-induced thrombocytopenia (CIT) in a phase 2 clinical trial of patients with gastrointestinal cancers. CIT is a major burden in cancer treatment and can cause treatment delays that significantly impact patients’ outcomes. The senior author of the study is Sylvester’s chief of the classical hematology service,

Read More